Characteristics of Patients With Ulcerative Colitis Initiating Vedolizumab Therapy in Real-World Clinical Practice

被引:0
|
作者
Khalid, Javaria M. [1 ]
Reynolds, Matthew [2 ]
Alam, Naufi L. [3 ]
Don, O'Hara [2 ]
Smyth, Michael D. L. [1 ]
机构
[1] Takeda Dev Ctr Europe Ltd, London, England
[2] Evidera, Lexington, MA USA
[3] Evidera, London, England
来源
关键词
D O I
10.14309/00000434-201510001-01946
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1946
引用
收藏
页码:S825 / S825
页数:1
相关论文
共 50 条
  • [31] Comparison of Real-World Healthcare Resource Utilization Among Advanced Therapy-Experienced Patients With Ulcerative Colitis Initiated on Ustekinumab or Vedolizumab
    Zhdanava, Maryia
    Kachroo, Sumesh
    Boonmak, Porpong
    Burbage, Sabree
    Shah, Aditi
    Korsiak, Jill
    Lefebvre, Patrick
    Kerner, Caroline
    Pilon, Dominic
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (12S): : S15 - S15
  • [32] REAL-WORLD EVIDENCE OF VEDOLIZUMAB THERAPY IN ULCERATIVE COLITIS AND CROHN'S DISEASE PATIENTS: FECAL CALPROTECTIN A VALID BIOMARKER OF MUCOSAL INFLAMMATION
    Cicerone, C.
    Luppino, I.
    Erboso, M.
    Paese, P.
    Leo, P.
    DIGESTIVE AND LIVER DISEASE, 2019, 51 : E239 - E239
  • [33] REAL WORLD EVALUATION OF PROLONGED CLINICAL RESPONSE WITH VEDOLIZUMAB IN CROHN'S DISEASE AND ULCERATIVE COLITIS PATIENTS TREATED IN A PRIVATE PRACTICE SETTING
    Ritter, Timothy E.
    Fourment, Chris
    Van Anglen, Lucinda J.
    Okoro, Tracy C.
    Hardin, Thomas C.
    INFLAMMATORY BOWEL DISEASES, 2018, 24 : S74 - S74
  • [34] Real World Experience With Vedolizumab as First-Line Therapy for the Treatment of Ulcerative Colitis
    Ritter, Timothy E.
    Mehta, Samantha A.
    Van Anglen, Lucinda J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S439 - S439
  • [35] REAL WORLD EVALUATION OF PROLONGED CLINICAL RESPONSE WITH VEDOLIZUMAB IN CROHN'S DISEASE AND ULCERATIVE COLITIS PATIENTS TREATED IN A PRIVATE PRACTICE SETTING
    Ritter, Timothy E.
    Fourment, Chris
    Van Anglen, Lucinda J.
    Okoro, Tracy C.
    Hardin, Thomas C.
    GASTROENTEROLOGY, 2018, 154 (01) : S105 - S105
  • [36] Real-world characteristics and complications of patients with Ulcerative Colitis receiving conventional therapy in the public healthcare system in Brazil
    Galhardi Gasparini, R.
    Yukie Sassaki, L.
    Lima Martins, A.
    Saad Hossne, R.
    Watanabe de Oliveira, R.
    Yang Santos, C.
    Biatti Barreto, T.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I443 - I443
  • [37] Real-world characteristics and complications of patients with Ulcerative Colitis receiving conventional therapy in the public healthcare system in Brazil
    Galhardi Gasparini, R.
    Yukie Sassaki, L.
    Lima Martins, A.
    Saad Hossne, R.
    Watanabe de Oliveira, R.
    Yang Santos, C.
    Biatti Barreto, T.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I443 - I443
  • [38] Commentary on the real-world effectiveness of vedolizumab in therapy-experienced ulcerative colitis: A response to Azzam et al.
    Alameel, Turki A.
    Alhashim, Howra W.
    SAUDI JOURNAL OF GASTROENTEROLOGY, 2025, 31 (02): : 100 - 101
  • [39] VEDOLIZUMAB(VDZ) REAL WORLD OUTCOMES IN ULCERATIVE COLITIS (UC)
    Pulusu, Samba Siva Reddy
    Srinivasan, Ashish
    Krishnaprasad, Krupa
    Cheng, Daniel
    Mogilevski, Tamara
    Flanagan, Emma
    Keung, Charlotte
    Wu, Yang
    Prosser, Ruth
    Sawyer, Elise A.
    Rizvi, Quart-Ul-Ain
    Su, Heidi Y.
    Leung, Wai K.
    Edmundson, Aleksandra
    Cooke, Sharon
    Mahy, Gillian
    Thin, Lena
    Radford-Smith, Graham L.
    Sparrow, Miles
    Andrews, Jane M.
    Connor, Susan J.
    Bampton, Peter A.
    Simon, Ghaly
    van Langenberg, Daniel R.
    Bell, Sally
    De Cruz, Peter
    Begun, Jakob
    Ng, Siew C.
    Travis, Simon P.
    Lawrance, Ian
    GASTROENTEROLOGY, 2018, 154 (06) : S836 - S836
  • [40] Good efficacy and safety of vedolizumab in Crohn's disease and ulcerative colitis in a real-world scenario
    Zingone, Fabiana
    Barberio, Brigida
    Compostella, Federico
    Girardin, Giulia
    D'Inca, Renata
    Marinelli, Carla
    Marsilio, Ilaria
    Lorenzon, Greta
    Savarino, Edoardo Vincenzo
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2020, 13